Tirilazad
Modify Date: 2024-01-09 23:43:19
Tirilazad structure
|
Common Name | Tirilazad | ||
|---|---|---|---|---|
| CAS Number | 110101-66-1 | Molecular Weight | 624.86 | |
| Density | 1.25g/cm3 | Boiling Point | 812.9ºC at 760mmHg | |
| Molecular Formula | C38H52N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 445.4ºC | |
Use of TirilazadTirilazad is a nonglucocorticoid, 21-aminosteroid that inhibits lipid peroxidation. Tirilazad can attenuate brain or spinal cord injury caused by trauma, stroke, ischemia and reperfusion injury. Tirilazad has antiviral activities against nCoV. Tirilazad is neuroprotective for ischaemic stroke, can be used for subarachnoid hemorrhage research[1][2][3]. |
| Name | (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one |
|---|---|
| Synonym | More Synonyms |
| Description | Tirilazad is a nonglucocorticoid, 21-aminosteroid that inhibits lipid peroxidation. Tirilazad can attenuate brain or spinal cord injury caused by trauma, stroke, ischemia and reperfusion injury. Tirilazad has antiviral activities against nCoV. Tirilazad is neuroprotective for ischaemic stroke, can be used for subarachnoid hemorrhage research[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
[1]. Bath PM, et al. Tirilazad for acute ischaemic stroke. Cochrane Database Syst Rev. 2001;(4):CD002087. |
| Density | 1.25g/cm3 |
|---|---|
| Boiling Point | 812.9ºC at 760mmHg |
| Molecular Formula | C38H52N6O2 |
| Molecular Weight | 624.86 |
| Flash Point | 445.4ºC |
| Exact Mass | 624.41500 |
| PSA | 72.88000 |
| LogP | 5.59120 |
| Vapour Pressure | 1.71E-26mmHg at 25°C |
| Index of Refraction | 1.646 |
| Pregna-1,4,9(11)-triene-3,20-dione,21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)erazinyl)-16-methyl-,(16alpha) |
| tirilazad of tirilazad |
| Tirilazad |
| Tirilazad (INN) |
| Tirilazad [INN:BAN] |
| Tirilazadum |
| Tirilazadum [INN-Latin] |